Anebulo Pharmaceuticals Reports Director/Officer Changes & Shareholder Votes
Ticker: ANEB · Form: 8-K · Filed: Apr 7, 2025 · CIK: 1815974
| Field | Detail |
|---|---|
| Company | Anebulo Pharmaceuticals, Inc. (ANEB) |
| Form Type | 8-K |
| Filed Date | Apr 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, shareholder-vote
TL;DR
Anebulo's leadership is changing, directors are being elected, and there's a shareholder vote coming up.
AI Summary
Anebulo Pharmaceuticals, Inc. filed an 8-K on April 7, 2025, reporting events as of April 4, 2025. The filing indicates a departure of directors or certain officers, the election of directors, and the appointment of certain officers. It also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with shareholder votes, can indicate internal shifts or strategic decisions that may carry inherent risks.
Key Players & Entities
- Anebulo Pharmaceuticals, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 001-40388 (company_id) — Commission File Number
- 85-1170950 (company_id) — IRS Employer Identification No.
FAQ
What specific changes occurred regarding directors or officers?
The filing indicates the departure of directors or certain officers, the election of directors, and the appointment of certain officers, but the specific names and details are not provided in this summary.
What is the date of the earliest event reported in this 8-K?
The earliest event reported is dated April 4, 2025.
What other items are covered in this 8-K filing besides personnel changes?
The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
What is the company's state of incorporation and fiscal year end?
Anebulo Pharmaceuticals, Inc. is incorporated in Delaware and its fiscal year ends on June 30.
What is the SIC code for Anebulo Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Anebulo Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 7, 2025 regarding Anebulo Pharmaceuticals, Inc. (ANEB).